GLP-1 Observer
Subscribe
Sign in
Home
Archive
About
Latest
Top
Pills, Implants, and Price Cuts
Week Of February 21 – February 27, 2026
Feb 27
•
Michael Parker, MD
1
Plateaus, Psoriasis, and Persistent Obesity
Week Of February 14 – February 20, 2026
Feb 20
•
Michael Parker, MD
1
Pivots, Patents, and Peptide Conjugates
Week Of February 7 – February 13, 2026
Feb 13
•
Michael Parker, MD
2
Heartbeats, Sleep, and Earnings
Week Of January 31 – February 6, 2026
Feb 6
•
Michael Parker, MD
2
January 2026
22.5%, Table Stakes, and the Gila Monster
Week Of January 24 – January 30, 2026
Jan 30
•
Michael Parker, MD
4
Airlines, Groceries, and Amylin
Week Of January 17 – January 23, 2026
Jan 23
•
Michael Parker, MD
3
From Peptides to Genetic Medicine
Week Of January 10 – January 16, 2026
Jan 16
•
Michael Parker, MD
2
Oral Wegovy Hits Shelves & The Maintenance Question
Week Of January 3 – January 9, 2026
Jan 10
•
Michael Parker, MD
3
Year-End Patent News and Phase 3 Moves
Week Of December 27 – January 2, 2026
Jan 3
•
Michael Parker, MD
4
December 2025
An Oral Milestone for GLP-1
Week Of December 20 – December 26, 2025
Dec 27, 2025
•
Michael Parker, MD
3
CagriSema and Orforglipron Head to FDA
Week Of December 13 – December 19, 2025
Dec 19, 2025
•
Michael Parker, MD
1
Oral Bets and Multi-Target Comparisons
Week Of December 6 – December 12, 2025
Dec 12, 2025
•
Michael Parker, MD
1
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts